ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 10c ; offers Guidance

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.29), $0.10 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $6 million versus the consensus estimate of $5.9 million.

GUIDANCE:

ClearPoint Neuro, Inc. sees FY2023 revenue of $25-27 million, versus the consensus of $26 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
• Booz Allen Hamilton (BAH) Tops Q1 EPS by 32c, Offers Guidance
• Noodles & Company (NDLS) Tops Q2 EPS by 26c ; Offers Guidance